Table 1 Studies of the cost of congenital rubella syndrome
From: Health economics of rubella: a systematic review to assess the value of rubella vaccination
First author [Reference] | de Owens [[15]] | Robinson [[16]] | Lanzieri [[14]] | Al-Awaidy [[13]] |
|---|---|---|---|---|
Country | Panama | Jamaica | Brazil | Oman |
Year | 1989 | 1998 | 2004 | 2006 |
WB income group | Upper middle | Upper middle | Upper middle | High |
Perspective | Health system* | Health system* | Health system | Societal |
Cost components measured | NR | NR | Diagnosis; OP care; Hospitalization Surgery; 1st year of FU | Diagnosis; OP care; Hospitalization Surgery; Drugs; Equipment; Special schools; Indirect costs |
Method of cost estimation | NR | NR | Micro-costing using reimbursement data | Micro-costing using accounts data (treatment costs); Human capital approach (for indirect costs) |
Time period for costing | Annual | Annual | Annual (1st year) | Lifetime |
Discounting (Rate) | NA | NA | NA | Yes (3%) |
Results (2012 US$) | $58,023 | $57,010 | $4,261 | $139,910 |
Sponsor | NR | NR | NR | Oman MOH* |